Clinical case of thrombotic microangiopathy in obstetric practice
摘要
Trombotic microangiopathy is heterogeneous group of the diseases united by a community of a histological and clinical implications at difference of pathogenetic mechanisms, presents clinical-morphological syndrome characterizing a lesion of vessels of a microcirculatory channel. Currently thrombotic microangiopathy include thrombotic thrombocytopenic purpura (TTP), atypical hemolytic uremic syndrome (aHUS), heparin-induced thrombocytopenia, HELLP-syndrome. One of the most important triggers of emergence of a thrombotic microangiopathy is pregnancy. The article describes the clinical observation of atypical hemolytic uremic syndrome in obstetric practice.
关于作者
M. Mochalova
Chita State Medical Academy
俄罗斯联邦
俄罗斯联邦
T. Belokrinitskaya
Chita State Medical Academy
俄罗斯联邦
俄罗斯联邦
T. Haven
Chita State Clinical Hospital “Regional Clinical Hospital”
俄罗斯联邦
俄罗斯联邦
E. Shifman
Vladimirsky MONIKI; Association of Obstetric Anesthesiologists-Reanimatologists
俄罗斯联邦
俄罗斯联邦
K. Shapovalov
Chita State Medical Academy
俄罗斯联邦
俄罗斯联邦
S. Kostromitin
Chita State Clinical Hospital “Regional Clinical Hospital”
俄罗斯联邦
俄罗斯联邦
参考
1. Fakhouri F., Vercel C., Fremeaux-Bacchi V. Obstetric Nephrology: AKI and Thrombotic Microangiopathies in Pregnancy. Clin. J. Am. Soc. Nephrol. 2012; 7: 2100-2106. DOI: 10.2215/CJN.13121211
2. Fakhouri F., Roumenina L., Provot F. et al. Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations. J. Am. Soc. Nephrol. JASN. 2010; 21(5): 859-867
3. Акиньшина С.В., Бицадзе В.О., Гадаева З.К., Макацария А.Д. Значение тромботической микроангиопатии в патогенезе акушерских осложнений. Акушерство, гинекология и репродукция. 2015; 9(1): 62-71. DOI: 10.17749/2070-4968.2015.9.2.062-71
4. Kentouche K., Voigt A., Schleussner E. et al. Pregnancy in Upshaw-Schulman syndrome. Hamostaseologie. 2013; May 29; 33(2): 144-8
5. Gaudet L., Ferraro Z.M., Wen S.W., Walker M. Maternal Obesity and Occurrence of Fetal Macrosomia: A Systematic Review and Meta-Analysis. Biomed. Res. Int. 2014; 2014: 640291. DOI: 10.1155/2014/640291
6. Torok T.J., Holman R.C., Chorba T.L. Increasing mortality from thrombotic thrombocytopenic purpura in the United States-analysis of national mortality data, 1968-1991. Am. J. Hematol. 1995; 50: 84-90
7. Козловская Н.Л., Коротчаева Ю.В., Боброва Л.А., Шилов Е.М. Акушерский атипичный гемолитико-уремический синдром: первый российский опыт диагностики и лечения. Нефрология. 2016; 20(2): 68-80
8. Батюшин М.М. Атипичный гемолитико-уремический синдром при беременности и HELLP-синдром. Вопросы дифференциальной диагностики. Клиническая нефрология. 2015; 2-3: 46-51
9. Isler C.M., Barrilleaux P.S., Magann E.F. et al. A prospective, randomized trial comparing the efficacy of dexamethasone and betamethasone for the treatment of antepartum HELLP (hemolysis, elevated liver enzymes, and low platelet count syndrome). Amer. J. Obstet. Gynec. 2001; 184: 1332-9
10. Katz V.L., Farmer R., Kuler J.A. Preeclampsia into eclampsia: Towards a new paradigm. Amer. J. Obstet. Gynec. 2000; 182: 1389-94
11. Figueroa J.E., Densen P. Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 1991; 4(3): 359-395
12. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 2001; 344(14): 1058-66. DOI: 10.1056/NEJM200104053441406
13. Rother R.P., Rollins S.A., Mojcik C.F. et al. Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria. Nature Biotech. 2007; 25(11): 1256-64. DOI: 10.1038/ nbt1344
评论
浏览:
756
Email this article 